Cargando…
_version_ 1785132516275912704
author Terekhanova, Nadezhda V.
Karpova, Alla
Liang, Wen-Wei
Strzalkowski, Alexander
Chen, Siqi
Li, Yize
Southard-Smith, Austin N.
Iglesia, Michael D.
Wendl, Michael C.
Jayasinghe, Reyka G.
Liu, Jingxian
Song, Yizhe
Cao, Song
Houston, Andrew
Liu, Xiuting
Wyczalkowski, Matthew A.
Lu, Rita Jui-Hsien
Caravan, Wagma
Shinkle, Andrew
Naser Al Deen, Nataly
Herndon, John M.
Mudd, Jacqueline
Ma, Cong
Sarkar, Hirak
Sato, Kazuhito
Ibrahim, Omar M.
Mo, Chia-Kuei
Chasnoff, Sara E.
Porta-Pardo, Eduard
Held, Jason M.
Pachynski, Russell
Schwarz, Julie K.
Gillanders, William E.
Kim, Albert H.
Vij, Ravi
DiPersio, John F.
Puram, Sidharth V.
Chheda, Milan G.
Fuh, Katherine C.
DeNardo, David G.
Fields, Ryan C.
Chen, Feng
Raphael, Benjamin J.
Ding, Li
author_facet Terekhanova, Nadezhda V.
Karpova, Alla
Liang, Wen-Wei
Strzalkowski, Alexander
Chen, Siqi
Li, Yize
Southard-Smith, Austin N.
Iglesia, Michael D.
Wendl, Michael C.
Jayasinghe, Reyka G.
Liu, Jingxian
Song, Yizhe
Cao, Song
Houston, Andrew
Liu, Xiuting
Wyczalkowski, Matthew A.
Lu, Rita Jui-Hsien
Caravan, Wagma
Shinkle, Andrew
Naser Al Deen, Nataly
Herndon, John M.
Mudd, Jacqueline
Ma, Cong
Sarkar, Hirak
Sato, Kazuhito
Ibrahim, Omar M.
Mo, Chia-Kuei
Chasnoff, Sara E.
Porta-Pardo, Eduard
Held, Jason M.
Pachynski, Russell
Schwarz, Julie K.
Gillanders, William E.
Kim, Albert H.
Vij, Ravi
DiPersio, John F.
Puram, Sidharth V.
Chheda, Milan G.
Fuh, Katherine C.
DeNardo, David G.
Fields, Ryan C.
Chen, Feng
Raphael, Benjamin J.
Ding, Li
author_sort Terekhanova, Nadezhda V.
collection PubMed
description Chromatin accessibility is essential in regulating gene expression and cellular identity, and alterations in accessibility have been implicated in driving cancer initiation, progression and metastasis(1–4). Although the genetic contributions to oncogenic transitions have been investigated, epigenetic drivers remain less understood. Here we constructed a pan-cancer epigenetic and transcriptomic atlas using single-nucleus chromatin accessibility data (using single-nucleus assay for transposase-accessible chromatin) from 225 samples and matched single-cell or single-nucleus RNA-sequencing expression data from 206 samples. With over 1 million cells from each platform analysed through the enrichment of accessible chromatin regions, transcription factor motifs and regulons, we identified epigenetic drivers associated with cancer transitions. Some epigenetic drivers appeared in multiple cancers (for example, regulatory regions of ABCC1 and VEGFA; GATA6 and FOX-family motifs), whereas others were cancer specific (for example, regulatory regions of FGF19, ASAP2 and EN1, and the PBX3 motif). Among epigenetically altered pathways, TP53, hypoxia and TNF signalling were linked to cancer initiation, whereas oestrogen response, epithelial–mesenchymal transition and apical junction were tied to metastatic transition. Furthermore, we revealed a marked correlation between enhancer accessibility and gene expression and uncovered cooperation between epigenetic and genetic drivers. This atlas provides a foundation for further investigation of epigenetic dynamics in cancer transitions.
format Online
Article
Text
id pubmed-10632147
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106321472023-11-10 Epigenetic regulation during cancer transitions across 11 tumour types Terekhanova, Nadezhda V. Karpova, Alla Liang, Wen-Wei Strzalkowski, Alexander Chen, Siqi Li, Yize Southard-Smith, Austin N. Iglesia, Michael D. Wendl, Michael C. Jayasinghe, Reyka G. Liu, Jingxian Song, Yizhe Cao, Song Houston, Andrew Liu, Xiuting Wyczalkowski, Matthew A. Lu, Rita Jui-Hsien Caravan, Wagma Shinkle, Andrew Naser Al Deen, Nataly Herndon, John M. Mudd, Jacqueline Ma, Cong Sarkar, Hirak Sato, Kazuhito Ibrahim, Omar M. Mo, Chia-Kuei Chasnoff, Sara E. Porta-Pardo, Eduard Held, Jason M. Pachynski, Russell Schwarz, Julie K. Gillanders, William E. Kim, Albert H. Vij, Ravi DiPersio, John F. Puram, Sidharth V. Chheda, Milan G. Fuh, Katherine C. DeNardo, David G. Fields, Ryan C. Chen, Feng Raphael, Benjamin J. Ding, Li Nature Article Chromatin accessibility is essential in regulating gene expression and cellular identity, and alterations in accessibility have been implicated in driving cancer initiation, progression and metastasis(1–4). Although the genetic contributions to oncogenic transitions have been investigated, epigenetic drivers remain less understood. Here we constructed a pan-cancer epigenetic and transcriptomic atlas using single-nucleus chromatin accessibility data (using single-nucleus assay for transposase-accessible chromatin) from 225 samples and matched single-cell or single-nucleus RNA-sequencing expression data from 206 samples. With over 1 million cells from each platform analysed through the enrichment of accessible chromatin regions, transcription factor motifs and regulons, we identified epigenetic drivers associated with cancer transitions. Some epigenetic drivers appeared in multiple cancers (for example, regulatory regions of ABCC1 and VEGFA; GATA6 and FOX-family motifs), whereas others were cancer specific (for example, regulatory regions of FGF19, ASAP2 and EN1, and the PBX3 motif). Among epigenetically altered pathways, TP53, hypoxia and TNF signalling were linked to cancer initiation, whereas oestrogen response, epithelial–mesenchymal transition and apical junction were tied to metastatic transition. Furthermore, we revealed a marked correlation between enhancer accessibility and gene expression and uncovered cooperation between epigenetic and genetic drivers. This atlas provides a foundation for further investigation of epigenetic dynamics in cancer transitions. Nature Publishing Group UK 2023-11-01 2023 /pmc/articles/PMC10632147/ /pubmed/37914932 http://dx.doi.org/10.1038/s41586-023-06682-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Terekhanova, Nadezhda V.
Karpova, Alla
Liang, Wen-Wei
Strzalkowski, Alexander
Chen, Siqi
Li, Yize
Southard-Smith, Austin N.
Iglesia, Michael D.
Wendl, Michael C.
Jayasinghe, Reyka G.
Liu, Jingxian
Song, Yizhe
Cao, Song
Houston, Andrew
Liu, Xiuting
Wyczalkowski, Matthew A.
Lu, Rita Jui-Hsien
Caravan, Wagma
Shinkle, Andrew
Naser Al Deen, Nataly
Herndon, John M.
Mudd, Jacqueline
Ma, Cong
Sarkar, Hirak
Sato, Kazuhito
Ibrahim, Omar M.
Mo, Chia-Kuei
Chasnoff, Sara E.
Porta-Pardo, Eduard
Held, Jason M.
Pachynski, Russell
Schwarz, Julie K.
Gillanders, William E.
Kim, Albert H.
Vij, Ravi
DiPersio, John F.
Puram, Sidharth V.
Chheda, Milan G.
Fuh, Katherine C.
DeNardo, David G.
Fields, Ryan C.
Chen, Feng
Raphael, Benjamin J.
Ding, Li
Epigenetic regulation during cancer transitions across 11 tumour types
title Epigenetic regulation during cancer transitions across 11 tumour types
title_full Epigenetic regulation during cancer transitions across 11 tumour types
title_fullStr Epigenetic regulation during cancer transitions across 11 tumour types
title_full_unstemmed Epigenetic regulation during cancer transitions across 11 tumour types
title_short Epigenetic regulation during cancer transitions across 11 tumour types
title_sort epigenetic regulation during cancer transitions across 11 tumour types
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632147/
https://www.ncbi.nlm.nih.gov/pubmed/37914932
http://dx.doi.org/10.1038/s41586-023-06682-5
work_keys_str_mv AT terekhanovanadezhdav epigeneticregulationduringcancertransitionsacross11tumourtypes
AT karpovaalla epigeneticregulationduringcancertransitionsacross11tumourtypes
AT liangwenwei epigeneticregulationduringcancertransitionsacross11tumourtypes
AT strzalkowskialexander epigeneticregulationduringcancertransitionsacross11tumourtypes
AT chensiqi epigeneticregulationduringcancertransitionsacross11tumourtypes
AT liyize epigeneticregulationduringcancertransitionsacross11tumourtypes
AT southardsmithaustinn epigeneticregulationduringcancertransitionsacross11tumourtypes
AT iglesiamichaeld epigeneticregulationduringcancertransitionsacross11tumourtypes
AT wendlmichaelc epigeneticregulationduringcancertransitionsacross11tumourtypes
AT jayasinghereykag epigeneticregulationduringcancertransitionsacross11tumourtypes
AT liujingxian epigeneticregulationduringcancertransitionsacross11tumourtypes
AT songyizhe epigeneticregulationduringcancertransitionsacross11tumourtypes
AT caosong epigeneticregulationduringcancertransitionsacross11tumourtypes
AT houstonandrew epigeneticregulationduringcancertransitionsacross11tumourtypes
AT liuxiuting epigeneticregulationduringcancertransitionsacross11tumourtypes
AT wyczalkowskimatthewa epigeneticregulationduringcancertransitionsacross11tumourtypes
AT luritajuihsien epigeneticregulationduringcancertransitionsacross11tumourtypes
AT caravanwagma epigeneticregulationduringcancertransitionsacross11tumourtypes
AT shinkleandrew epigeneticregulationduringcancertransitionsacross11tumourtypes
AT naseraldeennataly epigeneticregulationduringcancertransitionsacross11tumourtypes
AT herndonjohnm epigeneticregulationduringcancertransitionsacross11tumourtypes
AT muddjacqueline epigeneticregulationduringcancertransitionsacross11tumourtypes
AT macong epigeneticregulationduringcancertransitionsacross11tumourtypes
AT sarkarhirak epigeneticregulationduringcancertransitionsacross11tumourtypes
AT satokazuhito epigeneticregulationduringcancertransitionsacross11tumourtypes
AT ibrahimomarm epigeneticregulationduringcancertransitionsacross11tumourtypes
AT mochiakuei epigeneticregulationduringcancertransitionsacross11tumourtypes
AT chasnoffsarae epigeneticregulationduringcancertransitionsacross11tumourtypes
AT portapardoeduard epigeneticregulationduringcancertransitionsacross11tumourtypes
AT heldjasonm epigeneticregulationduringcancertransitionsacross11tumourtypes
AT pachynskirussell epigeneticregulationduringcancertransitionsacross11tumourtypes
AT schwarzjuliek epigeneticregulationduringcancertransitionsacross11tumourtypes
AT gillanderswilliame epigeneticregulationduringcancertransitionsacross11tumourtypes
AT kimalberth epigeneticregulationduringcancertransitionsacross11tumourtypes
AT vijravi epigeneticregulationduringcancertransitionsacross11tumourtypes
AT dipersiojohnf epigeneticregulationduringcancertransitionsacross11tumourtypes
AT puramsidharthv epigeneticregulationduringcancertransitionsacross11tumourtypes
AT chhedamilang epigeneticregulationduringcancertransitionsacross11tumourtypes
AT fuhkatherinec epigeneticregulationduringcancertransitionsacross11tumourtypes
AT denardodavidg epigeneticregulationduringcancertransitionsacross11tumourtypes
AT fieldsryanc epigeneticregulationduringcancertransitionsacross11tumourtypes
AT chenfeng epigeneticregulationduringcancertransitionsacross11tumourtypes
AT raphaelbenjaminj epigeneticregulationduringcancertransitionsacross11tumourtypes
AT dingli epigeneticregulationduringcancertransitionsacross11tumourtypes